NIH Weekly Funding Opportunities and Policy Notices
Funding Opportunity RFA-AG-22-015 from the NIH Guide for Grants and Contracts. The overarching objective of this funding opportunity announcement (FOA) is to develop and strengthen animal models for behavioral and social research in the interest of furthering the mechanistic understanding of how social and physical environmental factors contribute to aging processes and the etiology and progression of age-related conditions and diseases.
Notice NOT-AA-21-038 from the NIH Guide for Grants and Contracts
Notice NOT-AR-21-025 from the NIH Guide for Grants and Contracts
Notice NOT-OD-21-152 from the NIH Guide for Grants and Contracts
Notice NOT-AR-21-024 from the NIH Guide for Grants and Contracts
Notice NOT-AR-21-022 from the NIH Guide for Grants and Contracts
Notice NOT-DE-21-007 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-AG-22-024 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to support research that can lead to the development of evidence-based primary care screening tools and behavioral interventions to prevent abuse in at-risk older and vulnerable adults with mild cognitive impairment (MCI) and Alzheimers disease and Alzheimer's disease-related dementias (AD/ADRD) and their families.
Notice NOT-NS-21-077 from the NIH Guide for Grants and Contracts
Notice NOT-CA-21-096 from the NIH Guide for Grants and Contracts
Notice NOT-DA-21-002 from the NIH Guide for Grants and Contracts
Notice NOT-NS-22-003 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-DK-21-003 from the NIH Guide for Grants and Contracts. This FOA invites applications for a Biostatistics Research Center to participate in a clinical consortium to better understand youth-onset type 2 diabetes. A separate FOA (RFA-DK-21-002) invites Clinical Centers to recruit a cohort of early pubertal youth at risk for developing type 2 diabetes and study them through puberty. The ultimate goals of this consortium will be to 1) develop more precise prediction of which individuals are truly at risk for developing youth-onset T2D and identify determinants of progression from prediabetes to T2D so that, ultimately, targeted prevention approaches can be developed and tested; and 2) increase understanding of the physiologic drivers of youth-onset T2D to guide development of more effective strategies to achieve glycemic control and preserve beta cell function.
Funding Opportunity RFA-DK-21-002 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to ?c?r?e?a?t?e? ?a? ?c?l?i?n?i?c?a?l? consortium to recruit a cohort o?f early pubertal youth at risk for developing type 2 diabetes and study them th?r?o?ugh puberty. The ultimate goal of this undertaking will be to 1) develop more precise prediction of which individuals are truly at risk for developing you?t?h-onset T2D and identify determinants of progression from prediabetes to T2D so that, ultimately, targeted prevention approaches can be developed and tested; and 2) increase understanding ofthe physiologic drivers of youth-onset T2D to guide development of more effective strategies to achieve glycemic control and preserve beta cell function.
Notice NOT-AA-21-041 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-DK-21-013 from the NIH Guide for Grants and Contracts. This FOA invites applications for continuation of the Collaborative Islet Transplantation Registry? (CITR). Since 2001, this Registry has compiled and analyzed islet transplantation data with the intent to capture all clinical activity in North America as well as additional sites in other countries. Currently, data on both allo- and autotransplantation are collected. The registry will collect data and develop and maintain sophisticated databases to be used by the research community for publications? and presentations. CITR will also prepare an annual report available to the public summarizing outcomes of islet transplantation and trends over time as well as conduct an annual CITR meeting for contributing sites. Collection and analysis of this information? will contribute to identifying risk factors and key safety and efficacy determinants of successful? therapy ofislet transplantation as atreatment for patients with type 1 diabetes and pancreatectomy.
Notice NOT-AA-21-040 from the NIH Guide for Grants and Contracts
Elucidating the Roles of Transposable Elements in AD/ADRD and Aging (R01 Clinical Trial Not Allowed)
Funding Opportunity RFA-AG-22-021 from the NIH Guide for Grants and Contracts. The goal of this Funding Opportunity Announcement (FOA) is to support hypothesis-driven research to gain an understanding of the dysregulation of transposable elements (TE) and their contributions to Alzheimer's disease (AD) and Alzheimer's disease-related dementias (ADRD) and aging. This FOA encourages applications that investigate causal effects of TE activation in disease and aging and applications that model therapeutic interventions to facilitate the transition of the field from observational discovery towards a deeper mechanistic understanding of the function and regulation of TEs.
Notice NOT-EB-21-021 from the NIH Guide for Grants and Contracts
Notice NOT-AA-21-039 from the NIH Guide for Grants and Contracts